CBAK Energy to Report Second Quarter & First Half 2022 Unaudited Financial Results on Monday, August 15, 2022 August 9, 2022 9:00 am|DALIAN, China, Aug. 9, 2022 /PRNewswire/ — CBAK Energy Technology, Inc. (NASDAQ: CBAT) (“CBAK Energy”, or the “Company”), a…
'Carter' Director Byung-gil Jung Launches Multiverse-themed NFT Project Through ARKPIA August 9, 2022 9:00 am|
Availity to Acquire Diameter Health, a Leader in Clinical Data Interoperability August 9, 2022 9:00 am|Joint technology solution will deliver an integrated data interoperability platform that streamlines data acquisition and delivers clean, actionable,…
Offchain Labs Announces Launch of Arbitrum Nova Chain August 9, 2022 9:00 am|Arbitrum Nova, built on Arbitrum AnyTrust technology, will be feature low-cost transactions and strengthened security measures
Zeelandia Sees 83% Reduction in Time Taken to Prepare Customer Product Recommendations with Infor August 9, 2022 9:00 am|Global bakery ingredients business increases revenues and enhances customer experience with AI-driven product and pricing recommendations
THE VIKING SAIGON BEGINS INAUGURAL SEASON IN SOUTHEAST ASIA August 9, 2022 9:00 am|New Purpose-Built Ship Sails First Voyage on the Mekong River
Milliman announces opening of Bermuda office August 9, 2022 9:00 am|New office opening formalizes Milliman’s presence in vital insurance domicile
Flexential® Announces New Capabilities to Hosted Private Cloud – Advanced Access August 9, 2022 9:00 am|New FlexAnywhere™ solutions enhancements support rapid application mobility with advanced visibility and reporting
Twelve5's Rebel Hard Coffee Announces Re-Release of Fall and Winter Favorites for 2022 August 9, 2022 8:17 am|Pumpkin Spice, Peppermint Mocha, and Winter Wonderland Hard Latte Variety Packs are back
Saol Therapeutics Announces First Patient Enrolled in Phase 2 COMPASS Trial Evaluating the Safety and Efficacy Profile of SL-1002 for Treatment of Knee Pain Associated with Osteoarthritis August 9, 2022 8:15 am|SL-1002 is also being concurrently studied for the treatment of limb spasticity in the Phase 2 RAISE Trial…